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Primate Adult Brain Cell Autotransplantation, a Pilot Study
in Asymptomatic MPTP-Treated Monkeys
Jean-Franc¸ois Brunet,* D. Eugene Redmond, Jr.,† and Jocelyne Bloch*
*Department of Neurosurgery, Lausanne University Hospital, 1011 Lausanne, Switzerland
†Department of Psychiatry and Neurosurgery, Yale University School of Medicine, New Haven, CT, USA
Autologous brain cell transplantation might be useful for repairing lesions and restoring function of the
central nervous system. We have demonstrated that adult monkey brain cells, obtained from cortical biopsy
and kept in culture for a few weeks, exhibit neural progenitor characteristics that make them useful for brain
repair. Following MPTP treatment, primates were dopamine depleted but asymptomatic. Autologous cultured
cells were reimplanted into the right caudate nucleus of the donor monkey. Four months after reimplantation,
histological analysis by stereology and TH immunolabeling showed that the reimplanted cells successfully
survived, bilaterally migrated in the whole striatum, and seemed to have a neuroprotection effect over time.
These results may add a new strategy to the field of brain neuroprotection or regeneration and could possibly
lead to future clinical applications.
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INTRODUCTION ing contaminating pluripotent cells and committed neural
cells (16,50), the risks could be reduced for cell sources
that present a high rate of proliferation in vitro. There-The use of neural grafts to restore function after le-
sions or degeneration of the central nervous system has fore, autotransplantation of adult brain cells that were
shown to have a limited proliferation rate (9) representsbeen widely reported. Most of the transplantation expe-
rience acquired during the last two decades was focused an attractive alternative to bypass many of these caveats
and to elucidate mechanisms of neural repair.on fetal neuronal grafts (2,20,24,36,39). The objective
was to replace degenerated neurons, which were restricted Efforts have been made over the past few years to
develop appropriate methods to prepare long-term pri-to a limited brain area, such as the known pathologies
of Parkinson’s and Huntington’s disease (3,5,14,29,32, mary cultures from primate cortical biopsies (22,23,25,
30,47). After optimization of the procedure for brain cell35,37). However, despite the great enthusiasm generated
by this approach, ethical controversies, immune rejec- culture preparation, using a medium with preselected
fetal calf serum (pFCS), we succeeded in producingtion (38), poor tissue survival, and lack of fetal donors
remain major problems. long-term primary cultures of adult human brain cells
obtained from fresh or cryopreserved tissues collectedFor many years, the debate has evolved to include
the relative merits of using embryonic and adult stem during epilepsy or trauma neurosurgeries (7,8). Further-
more, previous studies suggested that the reconstructioncells for cell therapy (28). Embryonic and fetal stem
cells are also controversial, more likely to be rejected of the cortical circuitry responsible for sensory, motor,
or cognitive function may be possible by allogeneic stemwhen they mature, and fail to produce large numbers of
DA neurons after implantation (11,26,27,40,46). Recent cell transplantation in mature mouse neocortex (18).
In a preliminary study in a motor cortex lesionmethods for gene reprogramming of somatic cells to
pluripotent states would likely avoid immune rejection model, we have demonstrated that the autotransplanted
cells could survive, migrate, and acquire mature neu-(11,31,42,49). A recent report demonstrated, in a rat PD
model, the potential of such neurons derived from repro- ronal characteristics over time after reimplantation in the
donor cortex of mice (9). Here, we demonstrate for thegrammed cells to integrate in the brain (50). If it is pos-
sible to minimize the risk of tumor formation by separat- first time the feasibility of adult brain cell autotrans-
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plantation in the brain of asymptomatic MPTP-treated MPTP Treatment
monkeys. We show that the adult cortical brain cell au- Two weeks after biopsy, the four donor monkeys
tografts into the striatum can positively influence the were intramuscularly injected with MPTP 0.4 mg/kg/12
number of dopaminergic neurons in the substantia nigra h times three doses to reach a final dose of 1.2 mg/kg.
in mildly dopamine-depleted but asymptomatic parkin- The two MPTP control monkeys received the same
sonian monkeys. For these initial studies, we decided to doses and were studied over the identical time periods.
choose an asymptomatic low-dose MPTP model in order A parkinsonian factor and healthy behavior scores were
to determine biological effects prior to subjecting mon- derived from a prior study using a principal component
keys to the full effects of parkinsonian disabilities and factor analysis on 15,000 individual behavioral observa-
the more extensive care required to maintain them. tions from 77 MPTP or control monkeys (36,43,44), and
the score was averaged per week of observations. Indi-MATERIALS AND METHODS
vidual behavioral observations of the MPTP-treated
Animals monkeys confirmed their asymptomatic status because
they had normal healthy behavior and did not show par-Eight adult male St. Kitts green monkeys (Chloro-
cebus sabaeus) were used in accordance with the Na- kinsonian behavior.
tional Institute of Health Guide for the Care and Use of
Preparation of Cultured Primate Brain CellsLaboratory Animals and with approval of the Institu-
From Adult Tissuetional Animal Care and Use Committee. Animals were
trapped and maintained in individual cages at the St. The cortical biopsies were dissected with a razor
blade to obtain enriched fractions of gray matter. Pri-Kitts Biomedical Research Foundation (St. Kitts, West
Indies); they were fed regularly on a diet of fruit and mary cultures were generated by mincing and mechani-
cally triturating the tissue with fire-polished glass pi-monkey chow (Teklad) and had free access to water.
The eight animals were separated into three groups: two pettes of decreasing diameters. Cells were resuspended
at 50,000 cells/ml in RPMI-1640 medium (1×) withoutnormal controls without any intervention, two MPTP
controls that only received MPTP without surgical inter- L-glutamine (31870-025, Invitrogen AG, Basel, Switzer-
land) supplemented with NaHCO3 44 mM, 20% prese-vention, and four reimplanted animals that were first bi-
opsied, then treated with MPTP and reimplanted with lected fetal bovine serum (pFBS), and an antibiotic/anti-
mycotic cocktail (A7292 Sigma-Aldrich, St. Louis, MO,their autologous brain cells (Table 1).
USA) directly into 25-ml glass Erlenmeyer at 37°C in a
Biopsies water-saturated atmosphere containing 6.5% CO2/93.5%
air under horizontal agitation at 70 rpm. A cell suspen-The four adult St. Kitts African green donor monkeys
were deeply anesthetized with pentobarbital to achieve sion was plated on glass coverslips into a 24-well plate
under the same incubator conditions. Fifteen days later,and maintain a stage III surgical anesthesia under sterile
surgical conditions; the doses varied from 25 to 50 mg/ the concentration of serum was reduced to 10%. After
20 days, when cells became confluent on the coverslip,kg depending on duration. The animals were carefully
monitored for vital signs, EKG, and pO2 and given sup- the cells were cultured in medium without serum and
were maintained in these conditions until reimplantationplemental oxygen and room air by endotracheal tube if
needed. Biopsies (3 mm2) were surgically obtained from 10 days later.
the dorsolateral prefrontal right cortex (Fig. 1A–D),
Labeling and Preparing Cells for Transplantationplaced into tubes that were completely filled with Hiber-
nate A medium (Brain Bits, Springfield, IL, USA), and Cell aggregates from one flask were pooled by cen-
trifugation at 800 rpm. Supernatant was recovered forshipped from St. Kitts to Lausanne, Switzerland.
Table 1. Animal and Experimental Timetable
Time (Days)
No.
Group Animals B M B to M M to R M to S R to S
Ct N 2 no — — — —
Ct MPTP 2 no 1.2 mg/kg — — 132 —
Reimplanted 4 yes 1.2 mg/kg 14 20 143 122
B, biopsy; M, MPTP; R, reimplantation; S, sacrifice.
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resuspension. Aggregates were resuspended in 500 µl phosphate buffer pH 7.4, solution that contains 25%
glycerol (G7893, Sigma-Aldrich), 30% ethylene glycoldiluent C with 5 µM green fluorescent viable dye PKH67
(MINI67, Sigma-Aldrich) for 3 min. FCS (500 µl) was (33068, Ridel-de-Hae¨n, Seelze, Germany).
added for 1 min and aggregates washed three times with
RPMI medium. After the last wash, aggregates were re- Immunocytochemistry and Immunohistochemistry
suspended with the recovered medium previously centri- Brain cryosections were incubated in PBS with 0.1%fuged at 4000 rpm to eliminate cellular wastes. Tubes
casein (C8694, Sigma-Aldrich) and then incubated in
containing fluorescent dye-stained aggregates were com- PBS 0.3% bovine albumin with antibodies against thepletely filled for transportation at room temperature following antigens: glial fibrillary acidic protein (GFAP)from Lausanne to St. Kitts. For reimplantation, aggre- (monoclonal G3893, 1/1000, Sigma-Aldrich; polyclonalgates were settled and supernatant was partially removed
rabbit Z0334 1/500, Dako, Glostrup, Denmark), nestin
until a volume of 100 µl remained, in which the aggre- (AB 22 polyclonal rabbit, Chemicon, Millipore, Biller-gates were resuspended at a cell concentration of 3,000/µl. ica, MA, USA), doublecortin (guinea pig polyclonal
DCX AB5910, 1/1000, Chemicon, Millipore), tyrosineCell Reimplantation
hydroxylase (TH) (monoclonal MAB318, 1/1000, andThe four MPTP donor adult St. Kitts African green polyclonal MAB152, 1/500, Chemicon, Millipore), glial-
monkeys were deeply anesthetized under sterile surgical derived neutrophic factor (GDNF) (MAB212, 1/1000,
conditions as described for biopsy. The resuspended ag- R&D Systems Europe Ltd, Abingdon, GB). They weregregates were administered into the target site via a 22-
then washed and incubated with fluorescent or horserad-gauge 100-µl Hamilton syringe attached to a microinfu- ish peroxidase- conjugated secondary antibodies. After
sion device (Stoelting, Wood Dale, IL, USA). Insertion
the last washes, they were revealed for peroxidase activ-
of the needle was performed slowly and allowed to re- ity with diaminobenzidine or mounted in Vectashield
main at the target sites for a 2-min period before injec-
with DAPI to counterstain nuclei before fluorescent mi-
tion, and the cannula tip was permitted to remain in the
croscopic analysis or infrared fluorescence scanning (Od-implantation site for at least 2 min before removal. Sus- yssey LI-COR, Lincoln, NE, USA).pension was extruded at a maximum rate of 2 µl/min.
Needle withdrawal occurred at a rate of 1 mm/min for
Histological Observation and Quantification5 min, followed by a more rapid withdrawal for the re-
maining distance. Two sites in the right caudate nucleus Drawings and cell counting of immunostained sections
were made with an Olympus BX40 epifluorescence mi-(AP +23.1 mm and 19.1 mm, lateral 4 mm, +19mm above
the ear bar zero and AP +19.1 mm, lateral right 4 mm, croscope equipped with a motorized X–Y-sensitive
stage and a video CDD camera connected to a computer-+19 mm above) were injected with 50 µl per site of
PKH67-labeled aggregates corresponding to 280,000 ± ized image analysis system (Explora Nova, La Rochelle,
France). Images were acquired using three software pro-18,000 cells per animal (mean ± SD, four animals).
Culture medium was injected into the left caudate nu- grams (Mosaic, Morpho Expert, and Fluo3D, Explora
Nova, La Rochelle, France). Series of slices on wholecleus in the same animals. The control monkeys were
not injected. brain were observed to define the brain section where
PKH67 cells were detected. For stereological analysis,
Necropsy representative 50-µm slices separated by 750 µm in the
defined brain section were used. The edges of the sec-Four months after reimplantation, and nearly 5 months
after MPTP treatment, the monkeys were sacrificed us- tion and the structures such as caudate nucleus, puta-
men, and ventricles were outlined for each slice. Theing ketamine (8–10 mg/kg, IM) and sodium pentobarbi-
tal (30 mg/kg, IV, or more until loss of deep corneal threshold of green fluorescence intensity and the limit
of cell surface from 100 to 600 µm2 were applied toreflex). The two normal controls were sacrificed using
the same necropsy procedure and the two MPTP control automatically identify all PKH67 cells on 11 to 13 slices
depending on the cell migration (Mercator, Exploramonkeys were sacrificed at the same period of post
MPTP treatment. Monkeys were then perfused with hep- Nova, La Rochelle, France). A visual control for this
PKH67 cell identification was done on 20 of 2500–3500arinized saline and fixed with 4% paraformaldehyde in
phosphate buffer; brains were removed, postfixed for 12 fields per slices. The obtained models of the slices with
identified cells allowed 3D reconstruction and 3D cellh with 4% paraformaldehyde in phosphate buffer, and
cryopreserved in 30% sucrose solution before freezing. counting through computer-based stereological analysis
(Map3D, Explora Nova, La Rochelle, France). The totalSections (50 µm thick) were prepared with a cryotome
(HM560, MICROM, Volketswil, Switzerland) and were cell counts were compared with the number of im-
planted cells to obtain a percentage of survival and instored at −80°C until used in the cryoprotection 50 mM
790 BRUNET, REDMOND, AND BLOCH
parallel the percentage of cells per anatomical structures mals. The only complication related to the needle tract
was a cortical hemorrhage, which was not consideredcould be estimated.
TH immunolabeling were quantified on 10 cryosec- clinically significant, followed by a gliosis observed his-
tologically at the time of necropsy in case W802 (Fig.tions covering the caudate and the putamen by infrared
scanning (Odyssey LI-COR, Lincoln, NE, USA). Circles 1A, E, F). Individual behavioral observations of the
MPTP-treated monkeys (reimplanted or not) confirmedwere drawn in different structures to obtain the integral
intensity values, expressed in arbitrary units that reflect their asymptomatic status because they had normal
healthy behavior and did not show parkinsonian behav-the number of emitted photons per surface pixel unit;
for each animal, an integral intensity value was obtained iors.
In vitro, the monkey adult brain cells proliferated byfor each structure and substructure for right and left
hemispheres. showing different mitotic states in culture over time
(Fig. 2A–E) and expressed neuroectodermal and pro-GDNF immunolabeling was quantified as TH immu-
nolabeling with infrared intensity measurement done on genitor markers such as GFAP (Fig. 2F), neurofilament,
vimentin, or nestin as described in previous studiesfour cryosections covering the area where PKH67 reim-
planted cells were observed. (7,8). In order to facilitate reimplantation, cells were cul-
tured in suspension under slow agitation (50–75 rpmFor the stereology of the dopaminergic neurons in the
substantia nigra, TH neurons were counted on six sec- with an ES-W shaker-Kuhner). Cells obtained in suspen-
sion expressed the same markers (GFAP, vimentin, nes-tions covering anteroposterior extent of the whole sub-
stantia nigra. The sections were matched anatomically, tin, and doublecortin), as observed in monolayer cultures
(Fig. 2F). They formed aggregates that contained fewverifying that the cross sections of the substantia nigra
were similar in all animals. The criteria of DAB immu- cells (5–10) with GFAP-positive long processes that
surrounded small nestin-positive and doublecortin-posi-nostaining intensity, cell surface limits from 100 to 600
µm2, and a form coefficient between 0.4 and 0.8 were tive cells (300–1,000) (Fig. 2G).
Four months after reimplantation, the four monkeysdefined by measuring cell surface and form coefficient
on 20 TH positive neurons to detect TH neurons for the were sacrificed and the brains processed. The 3D recon-
struction done with 11 to 13 sections that cover the areaautomatic computer based on each section and to per-
form the 3D cell counting through computer-based ste- where PKH67-labelled cells were targeted showed that
reimplanted cells were viable and present not only in thereological analysis (Mercator, Explora Nova, La Ro-
chelle, France). reimplanted striatum (Fig. 3) but also in the contralateral
striatum and in the corpus callosum (Fig. 3). UnbiasedAll the immunolabeling were identically done for all
the animals for cell counting or intensity quantification stereological counting analysis obtained from the 3D
computerized reconstructions (Fig. 3) confirmed thatin order to compare the results despite the limited num-
ber of animals. To blindly collect the data, the slices 50.4 ± 14.6% (n = 4) of the autotransplanted cortical gray
matter cells survived (Table 2). The majority (59.83 ±were randomly labeled for the eight animals by a person
other than the observer. 3.95%, n = 4) of these cells were located in the im-
planted caudate nucleus. The remaining cells were dis-The values or ratios obtained with normal and MPTP
control animals were compared with expected values tributed primarily in the striatum (ipsilateral putamen
14.17 ± 0.95%, contralateral caudate nucleus 11.77 ±from previous studies, such as the number of TH neu-
rons in substantia nigra in normal and in asymptomatic 2.66%, contralateral putamen 0.32 ± 0.07%; n = 4). There
were 13.91 ± 6.06% (n = 4) of the reimplanted cells lo-MPTP controls or the decrease of TH in striatum after
MPTP; we compared these control groups to the group cated outside the striatum in the corpus callosum (Fig. 3,
Table 2). No reimplanted cells were detectable in otherof four reimplanted monkeys. Statistical differences
were determined using one-way analysis of variance and structures except for one monkey. For this particular
case (Fig. 3B), autotransplanted cell survival was lowerBonferroni Multiple Comparisons Test, using GraphPad
Instat software. than for the other three monkeys (30.65% compare to
49% to 65%) and 22.94% of the reimplanted cells were
RESULTS located in the needle tract as well as in the cortex where
a small hemorrhage took place and a significant gliosisThe locations of the prefrontal biopsies, performed in
four monkeys (Chlorocebus sabaeus), are illustrated was observed (Fig. 1A, E, F). In the four reimplanted
animals, gliosis was also observed in the striatum (Fig.(Fig. 1A–D). There were no signs of hemorrhage or
other complications at the site of the biopsies and they 4K, L).
To evaluate the phenotype of the autologous trans-were well tolerated by the animals. The dorsolateral part
of the caudate nucleus as the target of reimplantion sites planted cells, immunohistochemistry revealed that PKH67
cells still expressed neural stem cell markers such aswas precisely identified for the four reimplanted ani-
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Figure 1. General observations of re-implanted monkey brains. (A–D) Macroscopic pictures of the monkey brains W802, W808,
W818, and W825, respectively; arrowheads and gray spots correspond to the biopsy, the white arrows represent the injection tracts,
the dark arrow shows the hemorrhage that occurred in the W802 case (A). (E) The mosaic reconstruction of GFAP immunohistos-
taining (in dark) is a part of cortex at the level of the hemorrhage showed in (A) and revealed the gliosis that occurred under the
hemorrhage area. (F) Higher magnification of dark frame box (E) that shows hypertrophied GFAP-positive astrocytes in the gliosis.
Scale bar: (E) 500 µm, (F) 100 µm.
792 BRUNET, REDMOND, AND BLOCH
Figure 2. In vitro adult brain cell culture. (A–E) Hematoxylin staining of gray matter-derived
cells. (A) Classical monolayer coverslip culture after 3 weeks. (B–E) Example of four mitosis
stages observed in a proportion of less than 0.1%. (F) Nestin (green) and GFAP (red) immunolabe-
ling in coverslip culture where only very few GFAP cells were found. (G) Doublecortin (DCX)
(green) and GFAP (red) immunolabeling in suspension culture where aggregates were constituted
with a few GFAP cells with long processes that surround a large group (300–1,000) of DCX cells.
Scale bar: 100 µm.
nestin (Fig. 2A–F), but did not express TH (Fig. 4G–I) SN almost attained normal values: 106.33 ± 20.26% in
the right implanted side and 76.31 ± 11.79% in the leftor GFAP, even in the reimplanted caudate nucleus
where a gliosis took place (Fig. 4J–L). contralateral side (n = 4) (Fig. 6).
GDNF immunohistochemistry were quantified in theTH immunohistochemistry was quantified by gray
level analysis after peroxidase revelation (data not area where PKH67 cells were detected in the reimplanted
monkeys or in the corresponding area in controls. Theshown), and also following infrared scanning with the
LICOR Odyssey system (Fig. 5). Both analyses gave the average intensity values obtained revealed an important
increase of GDNF in reimplanted monkeys with a meansame results. In the two control low-dose MPTP-treated
monkeys, a significant depletion of the TH immunolabe- value of 98.9 ± 11.2 arbitrary infrared intensity units
compared to normal and MPTP controls with mean val-ling (48.74 ± 1.68% in the right caudate and 51.79 ±
2.11% in the left caudate) was observed only in the dor- ues of 52.5 ± 7.3 and 54.8 ± 13.8, respectively (Fig. 7).
solateral caudate nucleus compared to normal control
DISCUSSION(p < 0.001), but not in the rest of the striatum. This de-
creased TH intensity was less significant in the four re- As with human and macaque brain cell culture, we
succeeded in producing long-term primary cultures ofimplanted monkeys, and was limited to 30.89 ± 4.41%
in the reimplanted side (p < 0.05) and to 41.37 ± 3.26% St. Kitts green monkey brain cells from the gray matter-
enriched fraction. In vitro, we demonstrated that thesein the contralateral side (p < 0.01) (n = 4) (Fig. 5).
Stereological counts of TH-positive cells in substan- monkey adult brain cells proliferate and present a pro-
genitor/stem cell phenotype in culture over time. Thetia nigra (SN) showed a significant TH neuron depletion
in the MPTP control monkey SN (p < 0.01, ANOVA present study aimed to determine in vivo survival, mi-
gration, or other effects of these cells, derived from cor-Bonferroni) in both sides; the remaining TH neurons
represented 31.49 ± 11.93% compared to the control (n = tical gray matter cells that were cultured for 1 month
when reimplanted in the caudate nucleus of MPTP-2). In the four reimplanted monkeys, TH neurons in the
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Table 2. Distribution of Reimplanted Cells in the Braintreated dopamine-depleted monkeys from which the
Structures of the Four Monkeyscells were collected (an autograft).
After the biopsy, MPTP treatment induced a partial Animaldopamine depletion. This level of depletion was not suf-
ficient to induce grossly observable parkinsonian motor W802 W808 W818 W825
signs (12).
Right caudate 43,624 98,944 92,552 105,872In a previous study, we demonstrated that cells sur-
Left caudate 6,660 20,352 17,336 24,956vive in vivo over time in ibotenic acid-lesioned brains
Right putamen 11,880 24,024 21,248 21,976
Left putamen 192 580 584 520
Other 17,364 16,236 17,496 17,628
Tract 1 664 40 24 136
Tract 2 536 304 208 \ 208
Total 80,920 160,480 149,448 171,296
No. of implanted cells 264,000 286,000 302,000 263,000
Percentage of survival 30.65 56.11 49.49 65.13
but not in normal ones (9). Therefore, the asymptomatic
MPTP model allowed us to investigate the biology of
cortical cells in dopamine-depleted striatum without sig-
nificant morbidity of the animals. A previous study
showed a loss of 70% of TH-immunolabeled cells in the
substantia nigra in a group of six monkeys 20 days after
an identical MPTP treatment (19). The depletion of do-
pamine [29.6 ± 4.6% (19–44) of control in caudate and
42.0 ± 4.9% (28–79) in the putamen] was also observed
following long-term treatment (1 year after MPTP treat-
ment) in the striatum of a group of nine monkeys classi-
fied asymptomatic after MPTP treatment (12). These re-
sults showed the significant impact of MPTP on the
striatal level of dopamine even if there are no parkinso-
nian signs (12,19), and many investigators have agreed
that there is a threshold of 75–85% dopamine depletion
that is necessary for motor signs to appear (1,21).
The cells were stereotactically reimplanted into the
right caudate nucleus at the dorsolateral level that was
previously described to be the only affected area in
asymptomatic MPTP monkeys for TH immunolabeling
(12). Just prior to reimplantation, cells were stained for
Figure 3. Localization of PKH67-labeled cells 4 months after tracking with PKH67 green fluorescent viable dye that
reimplantation. (A–E) All four cases are represented by 3D irreversibly binds to viable cell membranes and does notreconstruction (Map3D Explora Nova, La Rochelle) to illus-
label resident host cells as already described for intrace-trate the distribution of PKH67 reimplanted cells in the stria-
tum and the corpus callosum. For each slice used for stereol- rebrally transplanted cells (17).
ogy, a model was established by drawing the edges of the In the reimplanted brain, the stereological counting
section (in red), the ventricles (in blue), the caudate nucleus revealed that autologous reimplanted cells survived at(in brown), and the putamen (in dark brown) and by pointing
an impressively high rate (50%) 4 months after reim-the PKH67 cells (in green points). Each 3D reconstruction was
plantation. In the other approaches, such as fetal progen-done with 11 to 13 models that corresponded to the slices 50
µm thick, separated by 750 µm, and represented the complete itor cell grafting, it has been shown that a large number
slice of the brain where PKH67 cells were found. This brain of transplanted cells (up to 70–90%) die after transplan-
section is illustrated for the case W808 (A, C). The dark tation (6,51), even if antideath strategies were used to
arrows in (A) correspond to the entry of needle tracts. Note improve this survival (10,33,34,45,48). The impressivethat in case W802 (B), some PKH67 cells were found near the
rate of the autologous brain cell survival could be relatedneedle tract and leading into the cortex (white arrow) where a
small hemorrhage took place. Scale bar: 10 mm. to the fact that acute or chronic rejection seems less ex-
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Figure 4. Phenotype of PKH67-labeled cells four months after reimplantation. The first column corresponds to the pictures of the
PKH67 fluorescent cells. The second column corresponds to the DAB immunostaining for nestin (B, E), TH (H), and GFAP (K).
The third column corresponds to the merged images of the first two first, respectively. In detail, as in all cases, in case W818,
PKH67 cells (in green) were observed near the implantation site (in rows A–C, G–I), in the whole striatum (row J–L), and in the
corpus callosum (row D–F). In (A–F), PKH67 cells (A, D) still express nestin revealed in brown (B, E) as shown by the merged
images (C, F). Note that all nestin-positive cells were PKH67 positive. In (G–L), no green PKH67-positive cells (G, J) express TH
(H), as shown in the merged image (I), or GFAP (K), as shown in the merged image (L). Scale bar: 100 µm.
tensive for brain cell autotransplantation than for the eral part of the caudate nucleus, which is the most TH-
depleted area of the striatum, as previously describedtypical allografts that constitute fetal tissue or grafts
from stem cell lines (6,41,48,51). (12) and as we demonstrated in the two control MPTP
monkeys. The migration observed in the four reim-Furthermore, these cells migrated antero-posteriorly
in the reimplanted striatum but also to the contralateral planted monkeys is consistent with the migratory ability
of neural stem cells demonstrated in adult rat brainstriatum through the corpus callosum. The large major-
ity of the reimplanted cells were found in the dorsolat- (13,15) and in MPTP monkey brain transplanted with
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human neural stem cells (4). The important migration Indeed, by using RaybioTM human cytokine array I (Ray-
Biotech, Inc.), the presence of neurotrophic factors suchand the presence of cells in the corpus callosum could
also be due to the injection target at the superior part of as GDNF or BDNF was shown in medium conditioned
by adult cortical brain cells (unpublished data), whichthe caudate nucleus. Our previous studies also showed
that autologous monkey brain cells migrate into the le- may contribute to a bystander effect. This hypothesis is
supported by the fact that the number of TH neurons insioned motor cortex (9). We hypothesize that this migra-
tory ability is related to the fact that adult cortical brain the substantia nigra is close to normal values and the
decrease of TH intensity is less important in the dorso-cells express DCX (Fig. 2G), the migrant neuroblast
marker, and probably respond to chemoattractant agents lateral caudate nucleus when autotransplantation has
been performed. It is also suggested by the immunode-promoting migration (4).
The fact that no PKH67 reimplanted cells expressed tection of a higher level of GDNF in the area where
reimplanted cells were found compared to controls.TH indicates that they do not participate in cell replace-
ment of dopamine neurons (which are not normally Moreover, the absence of PKH67 cells in the substantia
nigra suggests that this neuroprotective effect is pro-found in this target region anyway, but project there
from the SN); however, they seem to have a neuropro- vided by a distal retrograde effect.
This positive impact on nigral dopaminergic neuronstective effect, and may produce some growth factors.
Figure 5. TH immunohistology in the striatum 4 months after adult brain cell reimplantation.
Infrared intensity of TH immunolabeling was measured on 12 sections covering the striatum. The
sections were matched anatomically in each animal, verifying that the cross sections of the substan-
tia nigra were similar in all animals. (A) Example of representative scanned slices from each group
(normal, MPTP, and reimplanted). Immunolabeling infrared intensity was measured by drawing a
circle (white in part A) on each different substructure of the striatum after infrared scanning with
Odyssey software (LI-COR). Only the dorsolateral head of caudate nucleus showed a significant
decrease in all six MPTP-treated monkeys. (B) The graph represents the means with standard
deviation that were determined from values of three consecutive sections per animal per group.
Note that the decrease is more significant in the control MPTP animals than in four reimplanted
ones. Scale bar: 1 cm. A one-way ANOVA was performed with Bonferroni multiple comparison
post hoc test. Only the right side was reimplanted.
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Figure 6. TH-ir neurons in substantia nigra, 4 months after adult brain cell reimplantation. (A)
Two pictures per group showed the representative TH immunostaining obtained in the rostral and
caudal part of the subtantia nigra in the three groups (normal, MPTP, and reimplanted ones). The
sections were matched anatomically in each animal, verifying that the cross sections of the substan-
tia nigra were similar in all animals. (B) Three examples of models obtained by pointing the TH-
positive cells (as described in Materials and Methods) showed representative TH cell counting for
the three groups. Neuronal cells expressing TH were counted in whole substantia nigra on six
sections per animal covering anteroposterior extent of substantia nigra. (C) Graphs done with the
means that were determined from the values per animal per group. Scale bar: 1 cm. A one-way
ANOVA was performed with Bonferroni multiple comparison post hoc test. Only the right side
was reimplanted.
suggests two interpretations for future investigations: ei- months. In a mild dopamine-depleted MPTP monkey
model, these cells have been demonstrated to have ather the cells present a neuroprotective effect at the level
of the striatal dopaminergic processes that influence the neurotrophic effect on the TH neurons in the substantia
nigra and their processes in the dorsolateral caudate nu-nigral dopaminergic neurons, or the cells have the ability
to stimulate endogenous dopaminergic neurogenesis. cleus over time.
These encouraging results would support studies ofTaken together with our previous studies (7–9), these
results confirm that adult brain cells can be obtained, the therapeutic role of these cells in a symptomatic
model of Parkinson’s disease and to further explore theircryopreserved, and kept in culture before being reim-
planted in the donor, and survive in vivo at least 4 potential mechanisms. These results and their potential
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